true
Contact Us
Sales
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Customer Care
0800 917 8776
BDUK_customerservice@bd.com
BD® Cathena™ Safety IV Catheter with BD Multiguard™ Technology
Connect to confidence, care and comfort
- Overview
- Specifications
- Products & Accessories
- EIFU & Resources
- FAQ
How does this catheter contribute to intravenous (IV) safety?
Cathena™ Safety IV Catheter with BD Multiguard™ Technology elevates the level of safety by combining needlestick safety with blood control technology compared to a non-safety, non-blood control catheter.
Complications of IV therapy: understanding the risks
Approximately 90% of hospital patients receive IV therapy.1 Globally, 1 billion+ peripheral IV catheters (PIVCs) are placed every year.2 IV placement is the most common invasive hospital procedure worldwide.1 95% of IV catheters placed are PIVCs.1 Based on clinical studies, risks associated with PIVC use include:
Potentially high frequency of PIVC catheter complications
35–50% of hospitalised patients who receive a PIVC experience a complication of IV therapy.3
Occurance of blood exposure
In a study, when clinicians used a PIVC without blood control technology, blood leakage occurred 61% of the time,4 risking potential exposure to bloodborne pathogens (BBP).
Multiple PIVC insertion attempts5
An emergency department study suggests that first attempt insertion success ranges from 18–79%.6
Multiple insertion attempts increase the risk to clinicians of needlestick injury (NSI) and potential exposure to BBP, and undue pain and increased infection risk to the patient.6
BD Vialon™ Catheter Material and other features and benefits
When clinician safety and patient comfort and care are critical, Cathena™ Safety IV Catheter with BD Multiguard™ Technology**:
-
Eliminates the need for venous compression
during insertion, connections and disconnections, and blood draws, reducing the risk of blood exposure.**,7
-
Reduces blood exposure risk**
by stopping blood flow during connections and reconnections.^,7
-
Provides immediate visual confirmation
of vessel entry with BD® Instaflash™ Needle Technology, improving opportunities for first attempt insertion success.*,8,9
-
Provides protection from needlestick injuries (NSIs)
with integrated passive safety system.
-
Offers an ergonomic design
that is easily adaptable to preferred insertion techniques and provides enhanced control throughout the procedure.
-
Clinically demonstrated to reduce phlebitis
by up to 69% compared to fluorinated ethylene propylene (FEP)10-12 and up to 32% compared to polyurethane (PUR) with BD Vialon™.13
-
Supports longer IV dwell times,
with BD Vialon™ Catheter Material.††,14
-
Smooth, tapered catheter tip design
with smooth, tapered catheter tip design.**
How does Cathena™ Safety IV Catheter with BD Multiguard™ Technology work?
The Cathena™ Safety IV Catheter with BD Multiguard™ Technology is designed to enhance the confidence, care and comfort of clinicians and patients.
Together, we all play a part in preventing vascular access complications.
BD Vascular Access Management assessments
Our powerful evidence-based assessments, with analytics and benchmarks, are the first phase of BD Vascular Access Management—and the first step on the path to enhance patient safety, workflow efficiency and cost-effectiveness across the entire patient journey.
Please note, not all products, services, claims or features of products may be available or valid in your local area. Please check with your local BD Representative.
Please consult BD product labels and inserts relevant to your geography for any indications, contraindications, hazards, warnings, cautions and instructions for use. Any discussion and/or content regarding BD products is limited to this information and instructions for use.
*Compared to a non-notched needle
†Compared to an FEP catheter
^For up to 10 seconds
**Compared to a non-safety, non-blood control catheter
††Compared to PTFE catheter material
1. iData Research Inc. Global Market Report Suite for Vascular Access Devices and Accessories. 2020.
2. Alexandrou E, Ray-Barruel G, Carr PJ, et al. International prevalence of the use of peripheral intravenous catheters. Journal of Hospital Medicine. 2015;10(8):530-533.
3. Helm RE, Klausner JD, Klemperer JD, Flint LM, Huang E. Accepted but unacceptable: peripheral IV catheter failure. J Infus Nurse. 2015;38(3):189-203.
4. Haeseler G, Hildbrand M, Fritscher J. Efficacy and ease of use of an intravenous catheter designed to prevent blood leakage: A prospective observational study. J Vasc Access. 2015;16(3):233-236
5. Rickard C, Webster J, Wallis MC, et al. Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomised controlled equivalence trial. Lancet [serial online]. 2012;380:1066-1074.
6. Carr P, Rippey J, Budgeon C, Cooke M, Higgins N, Rickard C. Insertion of peripheral intravenous cannulae in the Emergency Department: factors associated with first-time insertion success. J Vasc Access. 2016;17(2):182-190.
7. Onia R, Eshu-Wilson I, Arce C, et al. Evaluation of a new safety peripheral IV catheter designed to reduce mucocutaneous blood exposure. CMRO. 2011;27(7):1339-1346.
8. van Loon FHJ, Timmerman R, den Brok GPH, Korsten EHM, Dierick-van Daele ATM, Bouwman ARA. The impact of a notched peripheral intravenous catheter on the first attempt success rate in hospitalized adults: block-randomized trial. JVA. 2021 DOI: 10.1177/1129729821990217.
9. Seetharam AM, Raju U, Suresh K. A randomized controlled study to compare first stick success with Instaflash technology: The FIRSST study. JVA. 2022 DOI:10.1177/11297298221080369.
10. Kus B, Buyukyilmaz F. Effectiveness of Vialon biomaterial versus Teflon catheters for peripheral intravenous placement: A randomized clinical trial. Jpn J Nurs Sci. 2020;e12328. https://doi.org/10.1111/jjns.12328.
11. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. Annals of Internal Medicine. 1991;114:845-854.
12. Gaukroger PB, Roberts JG, Manners TA. Infusion thrombophlebitis: a prospective comparison of 645 Vialon and Teflon cannulae in anaesthetic and postoperative use. Anaesthesia and Intensive Care. 1988;16:265-271.
13. Yasuda H, Rickard CM, Marsh N et al. Risk factors for peripheral intravascular catheter‑related phlebitis in critically ill patients: analysis of 3429 catheters from 23 Japanese intensive care units. Annals of Intensive Care 2022; https://doi.org/10.1186/s13613-022-01009-5.
14. Chhugani M, James M, Thokchom S. A randomized controlled trial to assess the effectiveness of Vialon™ cannula versus polytetrafluoroethylene (PTFE) cannula in terms of indwelling time and complications in patients requiring peripheral intravenous cannulation. International Journal of Science and Research (IJSR). 2015;4(12).
15. Richardson D, Kaufman L. Reducing blood exposure risks and costs associated with SPIVC insertion. Nurs Manage. 2011;42(12):31-34.
IV catheter sizes and flow rates
Without wings | With wings | IV catheter sizes | Gravity flow | Maximum power | Maximum power |
Cathena™ Safety IV Catheter with BD Multiguard™ Technology | |||||
| 386807 | 386815 | 24 G x 0.75 in 0.7 x 19 mm | 20 mL/min (1,200 mL/hr) | 3.5 mL/sec | 2.5 mL/sec |
| 386806 | 386813 | 22 G x 1.00 in 0.9 x 25 mm | 36 mL/min (2,160 mL/hr) | 6.0 mL/sec | 3.5 mL/sec |
| — | 386814 | 22 G x 2.00 in 0.9 x 51 mm | 29 mL/min (1,740 mL/hr) | 6.0 mL/sec | 3.5 mL/sec |
| 386803 | 386810 | 20 G x 1.00 in 1.1 x 25 mm | 64 mL/min (3,840 mL/hr) | 11.0 mL/sec | 7.0 mL/sec |
| 386804 | 386811 | 20 G x 1.25 in 1.1 x 32 mm | 60 mL/min (3,600 mL/hr) | 11.0 mL/sec | 7.0 mL/sec |
| 386805 | 386812 | 20 G x 2.00 in 1.1 x 51 mm | 52 mL/min (3,120 mL/hr) | 11.0 mL/sec | 7.0 mL/sec |
| 386801 | 386808 | 18 G x 1.25 in 1.3 x 32 mm | 94 mL/min (5,640 mL/hr) | 16.0 mL/sec | 10.0 mL/sec |
| 386802 | 386809 | 18 G x 2.00 in 1.3 x 51 mm | 87 mL/min (5,200 mL/hr) | 16.0 mL/sec | 10.0 mL/sec |
| 386900 | 386910 | 16 G x 1.25 in 1.7 x 32 mm | 190 mL/min (11,400 mL/hr) | 27.0 mL/sec | 18.0 mL/sec |
| 386901 | 386911 | 16 G x 2.00 in 1.7 x 51 mm | 176 mL/min (10,560 mL/hr) | 27.0 mL/sec | 18.0 mL/sec |
Please note, not all products, services, claims or features of products may be available or valid in your local area. Please check with your local BD Representative.
Please consult BD product labels and inserts relevant to your geography for any indications, contraindications, hazards, warnings, cautions and instructions for use. Any discussion and/or content regarding BD products is limited to this information and instructions for use.
true
Literature
BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.
Learn more
Training
BD offers training resources to help improve your clinical practices as part of our goal of advancing the world of health.
Learn more
true
Cathena™ Safety IV Catheter with BD Multiguard™ Technology FAQs
Yes. Cathena™ Safety IV Catheter are acceptable for use with power injectors up to 325 psi (2,240 kPa).
Yes. Cathena™ Safety IV Catheters are available with and without wings.
Cathena™ Safety Peripheral IV Catheter (PIVC) with BD Multiguard™ Technology is a multi-use blood control catheter that does not require venous compression during insertion and subsequent luer connection and disconnection.^
Cathena™ Safety IV Catheters feature BD Vialon™ catheter material. BD Vialon™ is a polyurethane material that has been clinically demonstrated to reduce phlebitis by up to 69% compared with fluorinated ethylene propylene (FEP)1-3 and by up to 32% compared with polyurethane (PUR).4
Cathena™ Safety IV Catheter features BD® Instaflash™ Needle Technology designed to provide immediate visual confirmation of vessel entry (flashback) and was clinically demonstrated to improve first-attempt insertion success, reducing painful hit-and-miss insertions.5,6,*
No. Cathena™ Safety IV Catheter has a passive needle shield that automatically covers the needle as it is removed from the catheter, protecting against needlestick injuries and exposure to blood.
Yes. Cathena™ Safety IV Catheter can be used to draw blood. BD Cathena™ Catheters are intended to be inserted into a patient’s peripheral vascular system for short-term use to sample blood, monitor blood pressure, or administer fluids.
Yes. The Cathena™ Safety IV Catheter is ergonomically designed to be easily adaptable to current insertion techniques, while the anti-rotation tab is designed to enhance tactile control during advancement.
Please note, not all products, services, claims or features of products may be available or valid in your local area. Please check with your local BD Representative.
Please consult BD product labels and inserts relevant to your geography for any indications, contraindications, hazards, warnings, cautions and instructions for use. Any discussion and/or content regarding BD products is limited to this information and instructions for use.
^For up to 10 seconds
*Compared to a non-notched needle
1. Kus B, Buyukyilmaz F. Effectiveness of Vialon biomaterial versus Teflon catheters for peripheral intravenous placement: A randomized clinical trial. Jpn J Nurs Sci. 2020;e12328. https://doi.org/10.1111/jjns.12328.
2. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. Annals of Internal Medicine. 1991;114:845-854.
3. Gaukroger PB, Roberts JG, Manners TA. Infusion thrombophlebitis: a prospective comparison of 645 Vialon and Teflon cannulae in anaesthetic and postoperative use. Anaesthesia and Intensive Care. 1988;16:265-271.
4. Yasuda H, Rickard CM, Marsh N et al. Risk factors for peripheral intravascular catheter‑related phlebitis in critically ill patients: analysis of 3429 catheters from 23 Japanese intensive care units. Annals of Intensive Care 2022; https://doi.org/10.1186/s13613-022-01009-5.
5. van Loon FHJ, Timmerman R, den Brok GPH, Korsten EHM, Dierick-van Daele ATM, Bouwman ARA. The impact of a notched peripheral intravenous catheter on the first attempt success rate in hospitalized adults: block-randomized trial. JVA. 2021 DOI: 10.1177/1129729821990217.
6. Seetharam AM, Raju U, Suresh K. A randomized controlled study to compare first stick success with Instaflash technology: The FIRSST study. JVA. 2022 DOI:10.1177/11297298221080369.
true